| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/05/2008 | WO2008067071A2 Immune system programming through b7-dc |
| 06/05/2008 | WO2008067056A2 Method of inhibiting coagulation with human anti-factor va antibodies and use thereof |
| 06/05/2008 | WO2008067040A2 Method of detecting ocular diseases and pathologic conditions and treatment of same |
| 06/05/2008 | WO2008066854A2 Methods and compositions for inducing apoptosis in cancer cells |
| 06/05/2008 | WO2008066774A2 INTERFERON-β PRODUCTION MODULATING LISTERIA STRAINS AND METHODS FOR USING SAME |
| 06/05/2008 | WO2008066631A2 Methods of disrupting quorum sensing to affect microbial population cell density |
| 06/05/2008 | WO2008066483A1 Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders |
| 06/05/2008 | WO2008066444A1 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 06/05/2008 | WO2008066443A1 Il-33 vaccine for the treatment of inflammatory conditions with a strong th2 component |
| 06/05/2008 | WO2008066057A1 Control of cell proliferation targeted for iqgap3 |
| 06/05/2008 | WO2008065636A2 Treatment of disease by modulating cf5 protein |
| 06/05/2008 | WO2008065384A2 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
| 06/05/2008 | WO2008065315A1 Immunization protocol against the 4 dengue serotypes |
| 06/05/2008 | WO2008065304A1 New drug for inhibiting, preventing or treatment of rheumatoid arthritis |
| 06/05/2008 | WO2008065053A1 Multi-modal cancer therapy using viral hitch-hiking |
| 06/05/2008 | WO2008064570A1 The use of granulin-epithelin precursor (gep) antibodies for detection and suppression of hepatocellular carcinoma (hcc) |
| 06/05/2008 | WO2008064540A1 Compositions comprising adeno-associated virus-mediated anti-angiogenic factor-hgfk1 and uses thereof |
| 06/05/2008 | WO2008064488A1 Influenza vaccine formulation |
| 06/05/2008 | WO2008064451A1 Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant |
| 06/05/2008 | WO2008064440A1 Vaccin against group a beta hemolytic streptococcus and respective process for obtaining thereof |
| 06/05/2008 | WO2008046615A3 Anti-ige vaccines |
| 06/05/2008 | WO2008037257A3 Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors |
| 06/05/2008 | WO2008013454B1 Immunogenic compounds and protein mimics |
| 06/05/2008 | WO2008012538A3 Live vaccine strains of francisella |
| 06/05/2008 | WO2007126825A3 Combined mucosal and parenteral immunization against hiv |
| 06/05/2008 | WO2007118214A3 Antibody compositions and methods for treatment of neoplastic disease |
| 06/05/2008 | WO2007113224A3 Conjugation process for pnag and a carrier protein |
| 06/05/2008 | WO2007112146A3 Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases |
| 06/05/2008 | WO2007108568A8 Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope |
| 06/05/2008 | WO2007098186A3 Adjuvant and vaccine compositions |
| 06/05/2008 | WO2007066188A3 Marked bovine viral diarrhea virus vaccines |
| 06/05/2008 | WO2007056301A3 Antibody therapy for treatment of diseases associated with gluten intolerance |
| 06/05/2008 | WO2007054537A8 Novel bacterium and vaccine |
| 06/05/2008 | US20080132683 Purification of immunoglobulins from solution (hybridoma cell culture supernatants, animal plasma or sera, or colostrum); solid phase synthesis |
| 06/05/2008 | US20080132534 Pharmaceutical composition comprising a macrolide immunomodulator |
| 06/05/2008 | US20080132463 Pharmaceutical use of alpha antigen or alpha antigen gene |
| 06/05/2008 | US20080132452 treating a an autoimmune condition; administering polypeptide; Goodpasture Syndrome, multiple sclerosis, systemic lupus erythematosus, cutaneous lupus erythematosus, pemphigus, pemphigoid and lichen planus |
| 06/05/2008 | US20080132448 Conserved neisserial antigens |
| 06/05/2008 | US20080131976 Novel G protein coupled receptor protein, DNA its ligand |
| 06/05/2008 | US20080131889 Novel human genes and gene expression products: II |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131526 Akt sensitization of cancer cells |
| 06/05/2008 | US20080131500 methods of inactivating a protein, such as cleaving a disulfide bond of a protein, that involve contacting the protein with a reducing agent, a denaturant, and a hydroxide ion, wherein the pH of the composition is about 10.0 to about 14.0. Also disclosed are methods of treating or preventing a disease |
| 06/05/2008 | US20080131495 method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation. |
| 06/05/2008 | US20080131465 Group a Streptococcus Crge Protein |
| 06/05/2008 | US20080131464 Vaccines |
| 06/05/2008 | US20080131463 Vaccination method for controlling coccidiosis in fowl |
| 06/05/2008 | US20080131462 Genus acidophilus, crispatus, gasseri, helveticus and/or jensenii; killing and inhibiting internalization of urogenital and/or gastrointestinal pathogens |
| 06/05/2008 | US20080131461 Using low neutralized recombinant adenoviral vectors harboring nucleic acids encoding circumsporozoite antigens from plasmodium falciparum and purified recombinant protein adjuvants; kits; dosage regimen |
| 06/05/2008 | US20080131460 Administration of monovalent vaccine comprising first serotype vaccinal virus followed 1 to 12 months later by tetravalent vaccine; kits |
| 06/05/2008 | US20080131459 Vaccines, diagnostic agents; expression vectors for heterologous genes; deletion mutants, pseudorevertants, transfectants |
| 06/05/2008 | US20080131458 Vaccine Adjuvants |
| 06/05/2008 | US20080131457 Use of alpha-toxin for treating and preventing staphylococcus infections |
| 06/05/2008 | US20080131456 Antibiotic resistance free vaccines and methods for constructing and using same |
| 06/05/2008 | US20080131455 Antigen Delivery Compositions And Methods Of Use |
| 06/05/2008 | US20080131453 Campylobacter Jejuni Outer Membrane Protein Immunogenic Composition |
| 06/05/2008 | US20080131452 Using primate hepadnavirus loop region polypeptide sequences as tool in developing vaccine to prevent and treat viral infection |
| 06/05/2008 | US20080131451 Human immunodeficiency virus-1 protein variants for use as tools in designing vaccines for prevention and treatment of highly variable viral pathogens |
| 06/05/2008 | US20080131450 Immunogenic complexes, preparation method thereof and use of same in pharmaceutical compositions |
| 06/05/2008 | US20080131449 Mimetic oligopeptide for use in prevntion and treatment of viral infection of pigs; veterinary medicine |
| 06/05/2008 | US20080131448 Using interleukin receptor as tool in treatment cell proliferative disorders; antitumor agents |
| 06/05/2008 | US20080131447 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy |
| 06/05/2008 | US20080131446 Vaccine Composition |
| 06/05/2008 | US20080131445 Cd127 expression inversely correlates with foxp3 and suppressive function of cd4+ tregs |
| 06/05/2008 | US20080131444 Rice yellow mottle virus (RYMV) vector for use tool in generation of reporter molecules for gene expression analysis |
| 06/05/2008 | US20080131443 Method and composition for reconforming multi-epitopic antigens to intiate an immune response |
| 06/05/2008 | US20080131442 Polymerase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/05/2008 | US20080131441 Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection |
| 06/05/2008 | US20080131440 Using ultra-low doses of monoconal, polycloncal or natural antibodies to treat infectious disease |
| 06/05/2008 | US20080131439 Using anti-neutrophil cytoplasmic antibody (ANCA) as diagnostic indicator of gastrointestinal disorders |
| 06/05/2008 | US20080131438 Antibodies to non-functional p2x7 receptor |
| 06/05/2008 | US20080131437 Using allelic variation in cell adhesion molecule (CD164) as tool in treatment and prevntion of skin, arthritic and gastrointestinal disorders |
| 06/05/2008 | US20080131436 Polypeptide Compounds for Inhibiting Angiogenesis and Tumor Growth |
| 06/05/2008 | US20080131435 Recombinant immunoglobulins to mediate cytotoxicity and treat cell proliferative disorders; immunotherapy |
| 06/05/2008 | US20080131434 Compositions and methods for diagnosing and treating cancer |
| 06/05/2008 | US20080131433 Fc Receptor Homolog Antibodies And Uses Thereof |
| 06/05/2008 | US20080131432 Using inflixmab to decrease serum level of tumor necrosis factor, prevent p53 translocation to mitochondria and maintain mitochondrial respiration to nervous system tissues; side effect reduction and antitumor agents |
| 06/05/2008 | US20080131431 CD47 related compositions and methods for treating immunological diseases and disorders |
| 06/05/2008 | US20080131430 Therapeutic Administration Of The Scrambled Anti-Angiogenic Peptide C16Y |
| 06/05/2008 | US20080131429 Reducing human breast or prostate tumors using monoclonal antibodies; immunotherapeutics; tissue targeted therapy; antitumor agents |
| 06/05/2008 | US20080131428 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 06/05/2008 | US20080131427 Using mismatch repair inhibition as tool in directed polypeptide evolution |
| 06/05/2008 | US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair |
| 06/05/2008 | US20080131425 Biomolecular coating for implants |
| 06/05/2008 | US20080131424 Method of treatment and agents useful for same |
| 06/05/2008 | US20080131423 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders |
| 06/05/2008 | US20080131422 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 06/05/2008 | US20080131421 Neisserial antigens |
| 06/05/2008 | US20080131400 Vector system |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131377 Pharmaceutical Aerosol Compositions |
| 06/05/2008 | US20080131374 Pneumococcal vaccine and tumor necrosis factor antibodies; c-reactive protein; drug screening |
| 06/05/2008 | US20080131373 Fab proteins; anticancer agents; immunoglobulins; gene expression inhibition; kits |
| 06/05/2008 | US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease |
| 06/05/2008 | US20080131365 Cancerous disease modifying antibodies |
| 06/05/2008 | US20080131363 Rs7 antibodies |
| 06/05/2008 | CA2673757A1 Poxviridae treatment |
| 06/05/2008 | CA2671217A1 New a.beta. conformer selective anti-a.beta. globulomer monoclonal antibodies |
| 06/05/2008 | CA2670965A1 Influenza vaccine formulation |
| 06/05/2008 | CA2670696A1 Ovr110 antibody compositions and methods of use |